These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8766424

  • 1. [5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas].
    Kerbl R, Urban CE, Ladenstein R, Schnellauf C, Sitzwohl C, Lackner H, Gleispach H, Fauler G, Ambros PF, Ambros IM, Rumpler S, Gadner H, Spuller E, Höfler G, Amann G, Kytir J, Mutz I.
    Wien Klin Wochenschr; 1996; 108(13):398-403. PubMed ID: 8766424
    [Abstract] [Full Text] [Related]

  • 2. Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.
    Kerbl R, Urban CE, Ladenstein R, Ambros IM, Spuller E, Mutz I, Amann G, Kovar H, Gadner H, Ambros PF.
    Med Pediatr Oncol; 1997 Jul; 29(1):1-10. PubMed ID: 9142198
    [Abstract] [Full Text] [Related]

  • 3. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J.
    J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
    [Abstract] [Full Text] [Related]

  • 4. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A, Zaizen Y, Ikeda K, Suita S, Ohgami H, Nagahara N, Sera Y, Akiyama H, Kawakami K, Uchino J.
    Cancer; 1991 Nov 01; 68(9):2037-44. PubMed ID: 1913552
    [Abstract] [Full Text] [Related]

  • 5. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T, Kohno S, Mimaya J, Hasegawa S, Urushihara N, Yoshida A, Kawano S, Kusafuka J, Horikoshi Y, Takashima Y, Aoki K, Hamazaki M.
    Pediatr Surg Int; 2004 Jan 01; 20(1):27-32. PubMed ID: 14689211
    [Abstract] [Full Text] [Related]

  • 6. [Screening for neuroblastoma in infants aged 6 months. A method of testing].
    Schrøder H, Møller J, Thomsen A, Skadborg R, Clausen N.
    Ugeskr Laeger; 1991 Dec 16; 153(51):3615-8. PubMed ID: 1776206
    [Abstract] [Full Text] [Related]

  • 7. Screening for neuroblastoma in the northern region of England. Laboratory aspects.
    Seviour JA, McGill AC, Craft AW, Parker L, Bell S, Cole M, Smith J, Hawkins E, Brown J, Dale GA.
    Am J Pediatr Hematol Oncol; 1992 Nov 16; 14(4):332-6. PubMed ID: 1456399
    [Abstract] [Full Text] [Related]

  • 8. A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations.
    Mathieu P, Frappaz D, Chauvin F, Combaret V, Vercherat M, Brunat-Mentigny M, David L, Esteve J, Favrot M, Fouillat V, Greffe J, Lasset C, Renaud P, Philip T.
    Early Hum Dev; 1996 Sep 20; 46(1-2):177-96. PubMed ID: 9019414
    [Abstract] [Full Text] [Related]

  • 9. [Early neuroblastoma detection in Germany. On the status of the Hamburg-Stuttgart cooperative pilot study].
    Schilling FH, Erttmann R, Dohrmann S, Erb N, Winkler K, Gross U, Treuner J.
    Klin Padiatr; 1992 Sep 20; 204(4):282-7. PubMed ID: 1518266
    [Abstract] [Full Text] [Related]

  • 10. Neuroblastoma screening in the United States: results of the Texas Outreach Program for neuroblastoma screening.
    Ater JL, Gardner KL, Foxhall LE, Therrell BL, Bleyer WA.
    Cancer; 1998 Apr 15; 82(8):1593-602. PubMed ID: 9554539
    [Abstract] [Full Text] [Related]

  • 11. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
    Takeuchi LA, Hachitanda Y, Woods WG, Tuchman M, Lemieux B, Brisson L, Bernstein M, Brossard J, Leclerc JM, Byrne TD.
    Cancer; 1995 Dec 01; 76(11):2363-71. PubMed ID: 8635044
    [Abstract] [Full Text] [Related]

  • 12. Neuroblastoma screening: labeling of HVA and VMA for stable isotope dilution gas chromatography-mass spectrometry.
    Gleispach H, Huber E, Fauler G, Kerbl R, Urban C, Leis HJ.
    Nutrition; 1995 Dec 01; 11(5 Suppl):604-6. PubMed ID: 8748233
    [Abstract] [Full Text] [Related]

  • 13. Screening for neuroblastoma in North America. 2-year results from the Quebec Project.
    Woods WG, Tuchman M, Bernstein ML, Leclerc JM, Brisson L, Look T, Brodeur GM, Shimada H, Hann HL, Robison LL.
    Am J Pediatr Hematol Oncol; 1992 Nov 01; 14(4):312-9. PubMed ID: 1456396
    [Abstract] [Full Text] [Related]

  • 14. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.
    Yamamoto K, Hayashi Y, Hanada R, Kikuchi A, Ichikawa M, Tanimura M, Yoshioka S.
    J Clin Oncol; 1995 Aug 01; 13(8):2033-8. PubMed ID: 7636545
    [Abstract] [Full Text] [Related]

  • 15. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
    Nishi M, Miyake H, Takeda T, Takasugi N, Hanai J, Kawai T.
    Jpn J Clin Oncol; 1990 Sep 01; 20(3):268-70. PubMed ID: 2255102
    [Abstract] [Full Text] [Related]

  • 16. Compliance in a screening program for neuroblastoma.
    Campion P, Woods WG, Lemieux B.
    Prev Med; 1998 Sep 01; 27(4):590-6. PubMed ID: 9672953
    [Abstract] [Full Text] [Related]

  • 17. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1986 Dec 01; 16(4):351-5. PubMed ID: 3795531
    [Abstract] [Full Text] [Related]

  • 18. A population-based study of the usefulness of screening for neuroblastoma.
    Woods WG, Tuchman M, Robison LL, Bernstein M, Leclerc JM, Brisson LC, Brossard J, Hill G, Shuster J, Luepker R, Byrne T, Weitzman S, Bunin G, Lemieux B.
    Lancet; 1986 Dec 01; 348(9043):1682-7. PubMed ID: 8973429
    [Abstract] [Full Text] [Related]

  • 19. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
    Scriver CR, Gregory D, Bernstein M, Clow CL, Weisdorf T, Dougherty GE, Auray-Blais C, Giguère R, Lemieux B, Laberge C.
    CMAJ; 1987 May 01; 136(9):952-6. PubMed ID: 3105859
    [Abstract] [Full Text] [Related]

  • 20. Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany.
    Berthold F, Baillot A, Hero B, Schurr P, Nerenz A, Hunneman DH, Sander J.
    J Clin Oncol; 1999 Apr 01; 17(4):1200. PubMed ID: 10561179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.